Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

112 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-15

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A descriptive study to characterize clinical, radiological, lung function and quality of life alterations in patients who survived a severe or critical disease caused by SARS-COV-2 virus, who were treated in the intensive care unit of a high complexity institution in Cali, Colombia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Respiratory Function 3 Months After Hospital Discharge in Critically Ill COVID-19 Patients

NCT05249842

COVID-19

COMPLETED

Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

NCT04410107

COVID-19 SARS-CoV-2 Infection

COMPLETED

Characteristics in Post Covid-19 Patients

NCT04514705

Coronavirus Infection

ACTIVE_NOT_RECRUITING NA

Relationship of Physical Condition and Functionality in Post-covid Patients

NCT05422950

PHYSICAL ACTIVITY

COMPLETED

Efficacy Of An Education Plan And Adherence Follow-Up To The Exercise In Patients With COPD

NCT05204498

Patient Adherence

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Severe and critical COVID-19 survivors

Radiological alterations assessed by chest radiography and/or thoracic computed tomography Lung function alterations assessed by spirometry, diffusing capacity for carbon monoxide, 6 minute walk.

Quality of life alterations: saint george respiratory questionnaire

chest radiography

Intervention Type RADIATION

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

thoracic computed tomography scan

Intervention Type RADIATION

6 and 12 months after hospital discharge, if the patient had a CT scan upon admission to the hospital. If the study is normal at 6 months it will not be repeated at 12 months.

spirometry

Intervention Type DIAGNOSTIC_TEST

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

Diffusing capacity of carbon monoxide

Intervention Type DIAGNOSTIC_TEST

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

6 minute walk test

Intervention Type DIAGNOSTIC_TEST

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

saint george respiratory questionnaire

Intervention Type DIAGNOSTIC_TEST

6 and 12 months after hospital discharge.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

chest radiography

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

Intervention Type RADIATION

thoracic computed tomography scan

6 and 12 months after hospital discharge, if the patient had a CT scan upon admission to the hospital. If the study is normal at 6 months it will not be repeated at 12 months.

Intervention Type RADIATION

spirometry

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

Intervention Type DIAGNOSTIC_TEST

Diffusing capacity of carbon monoxide

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

Intervention Type DIAGNOSTIC_TEST

6 minute walk test

6 and 12 months after hospital discharge. If the study is normal at 6 months it will not be repeated at 12 months.

Intervention Type DIAGNOSTIC_TEST

saint george respiratory questionnaire

6 and 12 months after hospital discharge.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 19 years old who had a positive test for SARS-COV-2 virus
* Patients with a severe and critical disease by SARS-COV-2, who were treated at the ICU of Fundación Valle del Lili, and survived
* Patients with chest radiography or CT scan at admission to the hospital